<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014893</url>
  </required_header>
  <id_info>
    <org_study_id>201900045</org_study_id>
    <nct_id>NCT05014893</nct_id>
  </id_info>
  <brief_title>Neural Mechanisms of Cognitive Assessment and Rehabilitation for Mild Cognitive Dysfunction</brief_title>
  <official_title>Neural Mechanisms of Cognitive Assessment and Rehabilitation for Mild Cognitive Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Research Center for Rehabilitation Technical Aids</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Research Center for Rehabilitation Technical Aids</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the neural mechanisms of cognitive function decline, cognitive&#xD;
      assessment methods for subjects with mild cognitive dysfunction (Mild cognitive impairment,&#xD;
      MCI, or cognitive decline milder than MCI), and the approaches used to improve and restore&#xD;
      cognitive function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cognitive assessment tools are used to assess cognitive function of the subjects, including&#xD;
      those aged 60 or older. Functional and structural MRI and EEG are applied to investigate the&#xD;
      neural mechanisms of cognitive function decline and effects of methods to improve and restore&#xD;
      cognitive function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 6, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cognitive function (SCD-9)</measure>
    <time_frame>Change from Baseline Cognitive test results at 3 months.</time_frame>
    <description>The SCD-9 questionnaire is used to assess cognitive function of participants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cognitive function (MoCA)</measure>
    <time_frame>Change from Baseline Cognitive test results at 3 months.</time_frame>
    <description>The Montreal Cognitive Assessment test is used to assess cognitive function of participants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cognitive function (AD8)</measure>
    <time_frame>Change from Baseline Cognitive test results at 3 months.</time_frame>
    <description>The AD8 test is used to assess cognitive function of participants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cognitive function (CDR)</measure>
    <time_frame>Change from Baseline Cognitive test results at 3 months.</time_frame>
    <description>The Clinical Dementia Rating (CDR) test is used to assess cognitive function of participants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Physical capacity (TUG)</measure>
    <time_frame>Change from Baseline physical capacity test results at 3 months.</time_frame>
    <description>The timed up and go (TUG) test is used to evaluate physical capacity of participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Physical capacity (chair standing)</measure>
    <time_frame>Change from Baseline physical capacity test results at 3 months.</time_frame>
    <description>The 30-second chair standing test is used to evaluate physical capacity of participants.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]</measure>
    <time_frame>Up to 24 months.</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v5.0.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mild Cognitive Impairment (MCI)</condition>
  <condition>Subjective Cognitive Decline (SCD)</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group, without specific treatments</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receives treatments to improve cognitive function.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>multi-modal targeted intervention (e.g., cognitive training, exercise, games)</intervention_name>
    <description>The Intervention group will be given recommended interventions tailored to individuals based on their risks (e.g., physical exercise programs, cognitive training, dietary advice, control of blood pressure and cholesterol, healthy diet, control obesity, stop smoking,reduce alcohol excess)</description>
    <arm_group_label>Cognitive training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults being able to walk at least a block, and&#xD;
&#xD;
          -  Adults with subjective cognitive decline (SCD), or&#xD;
&#xD;
          -  Adults with mild cognitive impairment (MCI), or&#xD;
&#xD;
          -  Adults with normal cognitive function&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of dementia&#xD;
&#xD;
          -  Adults who cannot follow the protocal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pengxu Wei</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Research Center for Rehabilitation Technical Aids</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Research Center for Rehabilitation Technical Aids</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100176</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 1, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>September 11, 2021</last_update_submitted>
  <last_update_submitted_qc>September 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Research Center for Rehabilitation Technical Aids</investigator_affiliation>
    <investigator_full_name>Pengxu Wei</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

